Dermatological Manifestation in Coronavirus Disease 2019 Patients in Iraq

Anfal L. Al-Harbawi; Qasim S. Al Chalabi; Hala N. Alsalman; Mohammad S. Saeed

doi:10.3889/oamjms.2021.7095

Authors

Anfal L. Al-Harbawi Department of Medicine, Dermatology Section, Arab Board of Dermatology (FABHS Dermatology and Venereology), Mosul University, Mosul, Iraq
Qasim S. Al Chalabi Department of Medicine, Dermatology Section, Arab Board of Dermatology (FABHS Dermatology and Venereology), Mosul University, Mosul, Iraq
Hala N. Alsalman Department of Medicine, Dermatology Section, Iraqi Board of Dermatology (FIBMS Dermatology and Venereology), Mosul University, Mosul, Iraq
Mohammad S. Saeed Dermatology Section, Arab Board of Dermatology (FABHS Dermatology and Venereology), Al Sadir Teaching Hospital in Misan, Basrah, Iraq

DOI:

https://doi.org/10.3889/oamjms.2021.7095

Keywords:

Coronavirus disease-19, Severe acute respiratory syndrome coronavirus 2, Skin manifestation, Lesion

Abstract

Background: Coronavirus disease-19 (COVID-19) is a growing pandemic around the globe that was initially discovered in Wuhan in December 2019. Despite the relatively high incidence of cutaneous manifestations in COVID-19, their role in early recognition and disease progression has not been fully investigated.

Aim of this study: To report the possible incidence of the cutaneous lesion in COVID 19 patients and to describe various cutaneous manifestations and their correlation with other clinical features in Covid-19 positive patients to facilitate diagnosis and prognostications toward this virus.

Methods: This research was conducted as a cross-sectional study. Skin lesions photography and their analysis were collected by dermatologists from 18 cities in Iraq between September 2020 to January 2021. The data were processed using statistical package SPSS version 23.

Results: A total of 3117 confirmed COVID-19 cases were included in this study. Around 268 patients developed skin lesions with age ranged between 8 to 84 years. Of these skin lesions, 46.2% developed during the illness with minority erupting during the prodromal phase, whilst 38.8% appeared after hospitalization. The most common skin lesion was in the form of urticarial 36.74% followed by herpetic lesions 28.4%, maculopapular rash 11.74% and the remainder being candidiasis, oral thrush, chilblains, and other skin conditions. The most affected area was the torso (46%) followed by limbs, face, fingers, and toes.

Conclusion: This study demonstrated the high incidence rate of dermatological lesions in different phases of COVID-19 with urticarial rash being the most frequent clinical pattern.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Potekaev NN, Zhukova OV, Protsenko DN, Demina OM, Khlystova EA, Bogin V. Clinical characteristics of dermatologic manifestations of COVID‐19 infection: Case series of 15 patients, review of literature, and proposed etiological classification. Int J Dermatol. 2020;59(8):1000-9. http://doi.org/10.1111/ijd.15030 PMid:32621287 DOI: https://doi.org/10.1111/ijd.15030

Casas CG, Català A, Hernández GC, Rodríguez-Jiménez P4, Fernández-Nieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-7. http://doi.org/10.1111/bjd.19163 PMid:32348545 DOI: https://doi.org/10.1111/bjd.19163

Guertler A, Moellhoff N, Schenck TL, Hagen CS, Kendziora B, Giunta RE, et al. Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic: Comparing a single surgical site with a COVID-19 intensive care unit. Contact Dermatitis. 2020;83(2):108-114. https://doi.org/10.1111/cod.13618 PMid:32452036 DOI: https://doi.org/10.1111/cod.13618

Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246-7. https://doi.org/10.1111/jdv.16471 PMid:32294259 DOI: https://doi.org/10.1111/jdv.16471

Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. https://doi.org/10.1056/NEJMoa2002032 DOI: https://doi.org/10.1056/NEJMoa2002032

Recalcati S. Cutaneous manifestations in COVID-19: A first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-3. https://doi.org/10.1111/jdv.16387 PMid:32215952 DOI: https://doi.org/10.1111/jdv.16387

Young S, Fernandez AP. Skin manifestations of COVID-19. Cleve Clin J Med. 2020;2020:ccc031. https://doi.org/10.3949/ccjm.87a.ccc031 PMid:32409442 DOI: https://doi.org/10.3949/ccjm.87a.ccc031

Türsen Ü, Türsen B, Lotti T. Cutaneous sıde-effects of the potential COVID-19 drugs. Dermatol Ther. 2020;33(4):e13476. https://doi.org/10.1111/dth.13476 PMid:32358890 DOI: https://doi.org/10.1111/dth.13476

Schulkes KJ, Van den Elzen MT, Hack EC, Otten HG, Bruijnzeel-Koomen CA, Knulst AC. Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: A retrospective study. Clin Transl Allergy. 2015;5(1):5. https://doi.org/10.1186/s13601-015-0049-8 PMid:25664168 DOI: https://doi.org/10.1186/s13601-015-0049-8

Genovese G, Colonna C, Marzano AV. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue? Pediatr Dermatol. 2020;37(3):435-6. https://doi.org/10.1111/pde.14201 PMid:32315079 DOI: https://doi.org/10.1111/pde.14201

Daneshgaran G, Dubin DP, Gould DJ. Cutaneous manifestations of COVID-19: An evidence-based review. Am J Clin Dermatol. 2020;21(5):627-39. https://doi.org/10.1007/s40257-020-00558-4 PMid:32865778 DOI: https://doi.org/10.1007/s40257-020-00558-4

Kaya G, Kaya A, Saurat JH. Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID- 19: Review of the literature. Dermatopathology. 2020;7(1):3-16. https://doi.org/10.3390/dermatopathology7010002 PMid:32608380 DOI: https://doi.org/10.3390/dermatopathology7010002

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. https://doi.org/10.1002/path.1570 PMid:15141377 DOI: https://doi.org/10.1002/path.1570

Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: Lessons learned from current evidence. J Am Acad Dermatol. 2020;83(1):e57-60. https://doi.org/10.1016/j.jaad.2020.04.094 PMid:32339706 DOI: https://doi.org/10.1016/j.jaad.2020.04.094